Mantoux test results and BCG vaccination status in TB-exposed children

Main Article Content

Fadilah Harahap
Ridwan M. Daulay
Muhammad Ali
Wisman Dalimunthe
Rini Savitri Daulay

Abstract

Background Tuberculosis (TB) infection is highly prevalent in Indonesia. The source of transmission of TB to a child is usually via an adult with sputum smear-positive pulmonary tuberculosis. The Mantoux test is a diagnostic tool for tuberculosis infection. The BCG vaccine has been used for the prevention of TB, but its efficacy is still debated. Objective To assess for an association between Mantoux test results and BCG vaccination in children who had contact with adult pulmonary tuberculosis and to assess for differences in Mantoux test induration with regards to nutritional status, age, type of TB contact, and time duration since BCG vaccination in BCG-vaccinated and BCG-unvaccinated children. Methods A cross-sectional study was conducted in FebruaryMarch 2011 on infants and children (aged 3 months to five years), who had household contact with adult pulmonary TB. We performed tuberculin (Mantoux) skin tests to detect TB infection in the children. Subjects were consisted of two groups: BCG-vaccinated and BCG-unvaccinated. Results Subjects were 100 children (50 BCG-vaccinated and 50 BCG-unvaccinated subjects). Positive Mantoux test results were observed in 9 vaccinated subjects and 33 unvaccinated subjects. The mean diameters of induration in the vaccinated and unvaccinated groups were 7.6 mm and 9.6 mm, respectively (95%CI of difference -4.25 to 0.20; P=0.074). In children who had household contact with sputum smear-positive adult pulmonary TB, BCG vaccination was a protective factor against TB infection, with an odds ratio (OR) of 0.113 (95%CI 0.045 to 0.286; P=0.0001). There were no significant differences in Mantoux test induration associated with nutritional status, age, type of TB contact, and duration since BCG vaccination, between the two groups. Conclusion BCG vaccination has a protective effect on TBexposed children, based on Mantoux test results. However, there are no differences in Mantoux test induration associated with nutritional status, age, type of TB contact, or duration since BCG vaccination, between the BCG-vaccinated and BCGunvaccinated groups.

Article Details

How to Cite
1.
Harahap F, Daulay RM, Ali M, Dalimunthe W, Daulay RS. Mantoux test results and BCG vaccination status in TB-exposed children. PI [Internet]. 1Mar.2015 [cited 20Sep.2019];55(1):7-2. Available from: https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/98
Section
Articles
Received 2016-07-12
Accepted 2016-07-12
Published 2015-03-01

References

1. Harries A, Maher D, Graham S. TB/HIV a clinical manual. Geneva: WHO; 2004. p.21.
2. Rahajoe NN, Basir D, Makmuri MS, Kartasasmita CB, editors. Pedoman nasional tuberkulosis anak. 2nd ed. Jakarta: UKK Respirologi PP IDAI; 2007.
3. Aditama TY, Kamso S, Basri C, Surya A, editors. Pedoman nasional penanggulangan tuberkulosis. 2nd ed. Jakarta: Departemen Kesehatan Republik Indonesia; 2008. p. 1-35.
4. Lienhardt C, Sillah J, Fielding K, Donkor S, Manneh K, Warndorff D, et al. Risk factors for tuberculosis infection in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics. 2003;111:e608-14.
5. Tornee S, Kaewkungwal J, Fungladda W, Silachamroon U, Akarasewi P, Sunakorn P. Risk factors for tuberculosis infection among household contacts in Bangkok, Thailand. Southeast Asian J Trop Med Public Health. 2004;35:375-83.
6. Bozaykut A, Ipek IO, Ozkars MY, Seren LP, Atay E, Atay Z. Effect of BCG vaccine on tuberculin skin tests in 1-6 year-old children. Acta Paediatr. 2002;91:235-38.
7. TB Indonesia, 2010. Situasi epidemiologi TB di Indonesia. [cited 2010 February 18]. Available from: http://tbindonesia.or.id/pdf/Data_tb_1_2010.pdf.
8. Pereira SM, Dantes OM, Ximenes R, Barreto M. BCG vaccine against tuberculosis: its protective effect and vaccination policies. Rev Saude Publica. 2007;41:59-66.
9. Inselman LS. Tuberculin skin testing and interpretation in children. Pediatr Asthma Allergy Immunol. 2003;16:225-35.
10. Alberaez MP, Nelson KE, Munoz A. BCG vaccine effectiveness in preventing tuberculosis and its interaction with human immunodeficiency virus infection. Int J Epidemiol. 2000;29:1085-91.
11. Gie RP, Beyer N, Enarson DA. Epidemiology of childhood tuberculosis. In: Schaaf HS, Zumla AI, editors. Tuberculosis: a comprehensive clinical reference. Cape Town: Saunders; 2009. p. 38-43.
12. Singh M, Mynak ML, Kumar L, Mathew JL, Jindal SK. Prevalence and risk factors for transmission of infection among children in household contact with adults having pulmonary tuberculosis. Arch Dis Child. 2005;90:624-8.
13. Aziz N, Hasan S, Munir M, Tayyab M, Chaudrhy NA. Risk to household contacts of tuberculous patients based on Mantoux test and antibody titre. J Ayub Med Coll Abbottabad. 2008;20:47-50.
14. World Health Organization. Global epidemiology of tuberculosis. Geneva: WHO; 2011.
15. Handayani S. Respon imunitas seluler pada infeksi tuberculosis paru. Cermin Dunia Kedokteran. 2002;137:33-36.
16. Department of Health & Human Services. TB elimination tuberculin skin testing. [cited 2010 June]. Available from: http://www.cdc.gov/tb.
17. NHS Department of Health Publications. The Mantoux test administration, reading, and interpretation. [cited 2010 June]. Available from: http://www.immunisation.nhs.uk.
18. Enarson DA. Use of the tuberculin skin test in children. Pediatr Respir Rev. 2004;5:S135-7.
19. Miller FJW. Tuberculin sensitivity and the tuberculin test. In: Miller FJW, editor. Tuberculosis in children: evolution, epidemiology, treatment, prevention. London: Churchill Livingstone; 1982. p. 18-36.
20. Garcia-Sancho F MC, Garcia-Garcia L, Jimenez-Corona ME, Palacios-Martinez M, Ferreyra-Reyes LD, Canizales-Quintero S, et al. Is tuberculin skin testing useful to diagnose latent tuberculosis in BCG-vaccinated children? Int J Epidemiol. 2006;35:1447–54.
21. Diel R, Ernst M, Doscher G, Visuri-Karbe L, Greinert U, Niemann S, et al. Avoiding the effect of BCG vaccination in detecting Mycobacterium tuberculosis infection with a blood test. Eur Respir J. 2006;28:16-23.
22. Reid JK, Ward H, Marciniuk D, Hudson S, Smith P, Hoeppner V. The effect of neonatal bacille Calmette-Guerin vaccination on purified protein derivative skin test results in Canadian aboriginal children. Chest. 2007;131:1806-10.
23. Rathi SK, Akhtar S, Rahbar MH, Azam SI. Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulmonary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis. 2002;6:851-7.
24. Centers for Disease Control and Prevention. The role of BCG vaccine in the prevention and control of tuberculosis in the United States: a joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices. MMWR. 1996;45:1-19.
25. Soysal A, Millington KA, Bakir M, Dosanjh D, Aslan Y, Deeks JJ, et al. Effect of BCG vaccination on risk of Mycobacterium tuberculosis infection in children with household tuberculosis contact: a prospective community-based study. Lancet. 2005;366:1443-51.
26. Sakha K, Behbahan AG. Immunogenicity of neonatal BCG vaccination in children entering primary school. Pak J Biol Sci. 2008;11:930-3.